>>> US After Hours Summary: RPRX +65% after positive clinical data; VR


After Hours Summary: RPRX +65% after positive clinical data; VRX -2% after report that a bondholder intends to call default on Co

After Hours Gainers:

Companies trading higher in after hours in reaction to earnings/guidance: CSX +0.6%

Companies trading higher in after hours in reaction to news: RPRX +65.2% (reports 'positive' clinical data for vaginal Proellex in women with severe menstrual bleeding due to uterine fibroids), ACUR +12.7% (announces FDA fast track designation for the development of LTX-04), MDVN +8.8% (Bloomberg report discussing potential bid from Sanofi (SNY)), APHB +8.3% (presented data at the ECCMID summarizing both the in vitro and in vivo activity of its proprietary, investigational phage mix AB-PA01), PTIE +6.7% (FDA determines NDA resubmission for Remoxy is sufficiently complete to permit a substantive review)

After Hours Losers:

Companies trading lower in after hours in reaction to news: RICE -3.4% (announces 23.5 mln share public offering of common stock), VRX -2.4% (The WSJ reports that a VRX bondholder intends to declare default on the Co for failing to file its 10-K